Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Nov 1999

Phillips K A, Andrulis I L, Goodwin P J

Abstract excerpt

PURPOSE: To review the preclinical and clinical studies relevant to the prognosis and prognostic associations of BRCA1- and BRCA2-associated breast carcinomas, with an emphasis on research methodology. METHODS: Reports of relevant studies obtained from a MEDLINE search, and references from these articles, were critically reviewed. RESULTS: Consistent associations with both favorable (medullary or atypical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Genes, BRCA1

Share to Heterozygote

Share to Neoplasm Proteins

Share to Prognosis

Share to Transcription Factors

Source

Identifiers

PMID: 10550164
DOI: 10.1200/JCO.1999.17.11.3653

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?PMID 10550164Read ↗

BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis.Semantic proximity Read ↗

Clinical management of women with genomic BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.Semantic proximity Read ↗

BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management.Semantic proximity Read ↗

The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in <i>BRCA1</i> and <i>BRCA2</i>Semantic proximity Read ↗

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).Semantic proximity Read ↗

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypesSemantic proximity Read ↗

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review.Semantic proximity Read ↗

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.Semantic proximity Read ↗

The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study.Semantic proximity Read ↗

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.Semantic proximity Read ↗

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.